Trends & Analysis

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and patients can (and will) be […]

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. Sophia Ktori outlines the importance of data integrity in labs at every stage of product development and manufacturing on behalf of SiLA.  The concept of data integrity hinges on the need to safeguard and guarantee the consistency, completeness […]

Dr Pirkko Muhonen, Senior Field Application Scientist, Nucleic Acid Therapeutics, at Thermo Fisher Scientific, shares what’s next for RNA-based medicine post-pandemic with DDW. With SARS-CoV-2 circulating the globe and leading to over five million deaths worldwide1, all eyes are on the critical role messenger RNA (mRNA) vaccines are playing in helping to fight the ongoing […]

Lu Rahman asks Laura Hinton, Operations Director at Gentronix, to offer some insight into the contract research organisation (CRO) market and how Gentronix is making its presence known in this sector.  Gentronix is a specialist contract research organisation (CRO) based in the UK, focused on delivering predictive toxicology products and services to global chemical sectors. Gentronix offers a portfolio of genotoxicity products and services, supporting clients from […]

Click here to watch this as a video Lithuania is dedicating time and resources establishing itself as a life sciences and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing […]

2022’s World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working to close this gap.  World Cancer Day is a […]

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3 and many more internationally. A year before that, Covid-19 […]

Medidata reflects on how clinical trials have evolved over the past year, as well as emerging patterns and drivers of change for the coming year. Paul O’Donohoe and Fiona Maini from Medidata explain.  1. The future of clinical trials is decentralised  Decentralised clinical trials, described as the ‘new normal’ in clinical research, harness remote technologies to enable patients to participate in […]

Professor Sobha Sivaprasad, Professor of Retinal Clinical Studies, UCL Institute of Ophthalmology, and Consultant Ophthalmologist, Moorfields Eye Hospital, UK discusses unmet needs in DME therapeutics and how they could be addressed by sustained release ophthalmic steroids administered with novel suprachoroidal drug delivery methods.  Diabetic eye disease is a growing global concern. Between 2019 and 2045, the number […]

Slavé Petrovski and Andrew Harper, Centre for Genomics Research, AstraZeneca, outline the implications and insight offered by the recent publication of an AstraZeneca-authored paper “Rare variant contribution to human disease in 281,104 UK Biobank exomes”.  In August 2021, Nature published the largest and most comprehensive evaluation of the role rare genetic variants have across human disease. Performed in ~300,000 UK […]